NovaBridge Biosciences Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-07: Form 20-F; Period of report 2025-12-31; Description 20-F; Document nbp-20251231.htm.
- 2025-04-03: Form 20-F; Period of report 2024-12-31; Description 20-F; Document imab-20241231.htm.
- 2024-04-30: Form 20-F; Period of report 2023-12-31; Description FORM 20-F; Document imab-20231231x20f.htm.
- 2023-05-01: Form 20-F; Period of report 2022-12-31; Description FORM 20-F; Document imab-20221231x20f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-07 | 20-F | 2025-12-31 | 20-F | nbp-20251231.htm |
| 2025-04-03 | 20-F | 2024-12-31 | 20-F | imab-20241231.htm |
| 2024-04-30 | 20-F | 2023-12-31 | FORM 20-F | imab-20231231x20f.htm |
| 2023-05-01 | 20-F | 2022-12-31 | FORM 20-F | imab-20221231x20f.htm |
| 2022-04-29 | 20-F | 2021-12-31 | FORM 20-F | d231634d20f.htm |
| 2021-04-28 | 20-F | 2020-12-31 | FORM 20-F | d10811d20f.htm |
| 2020-04-29 | 20-F | 2019-12-31 | FORM 20-F | d882254d20f.htm |